Samantha L. Shterengarts

Array ( [id] => 8371398 [patent_doc_number] => 20120220781 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2012-08-30 [patent_title] => 'Process for preparing 1,3-disubstituted pyrazole compounds' [patent_app_type] => utility [patent_app_number] => 13/505909 [patent_app_country] => US [patent_app_date] => 2010-10-28 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 15903 [patent_no_of_claims] => 19 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13505909 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 7774288 [patent_doc_number] => 08119624 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2012-02-21 [patent_title] => 'Fused phenyl amido heterocyclic compounds' [patent_app_type] => utility [patent_app_number] => 12/913059 [patent_app_country] => US [patent_app_date] => 2010-10-27 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 136921 [patent_no_of_claims] => 7 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 6 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/08/119/08119624.pdf [firstpage_image] =>[orig_patent_app_number] => 12913059 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 7811365 [patent_doc_number] => 08133896 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2012-03-13 [patent_title] => 'Pyrimidine derivatives which are antagonist of the vitronectin receptor' [patent_app_type] => utility [patent_app_number] => 12/911691 [patent_app_country] => US [patent_app_date] => 2010-10-25 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 36315 [patent_no_of_claims] => 13 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 7 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/08/133/08133896.pdf [firstpage_image] =>[orig_patent_app_number] => 12911691 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 4471496 [patent_doc_number] => 07943799 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2011-05-17 [patent_title] => 'Method for producing optically active cycloalkylidenebisoxazoline compound and intermediate thereof' [patent_app_type] => utility [patent_app_number] => 12/908250 [patent_app_country] => US [patent_app_date] => 2010-10-20 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 10857 [patent_no_of_claims] => 4 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 11 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/07/943/07943799.pdf [firstpage_image] =>[orig_patent_app_number] => 12908250 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 8496467 [patent_doc_number] => 20120295875 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2012-11-22 [patent_title] => 'BORON-CONTAINING SMALL MOLECULES AS ANTIPROTOZOAL AGENTS' [patent_app_type] => utility [patent_app_number] => 13/503016 [patent_app_country] => US [patent_app_date] => 2010-10-19 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 2 [patent_figures_cnt] => 2 [patent_no_of_words] => 29286 [patent_no_of_claims] => 12 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13503016 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 5954392 [patent_doc_number] => 20110034514 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2011-02-10 [patent_title] => '5-Lipoxygenase-Activating Protein (FLAP) Inhibitors' [patent_app_type] => utility [patent_app_number] => 12/906325 [patent_app_country] => US [patent_app_date] => 2010-10-18 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 15 [patent_figures_cnt] => 15 [patent_no_of_words] => 86506 [patent_no_of_claims] => 26 [patent_no_of_ind_claims] => 8 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0034/20110034514.pdf [firstpage_image] =>[orig_patent_app_number] => 12906325 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 8336166 [patent_doc_number] => 20120202867 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2012-08-09 [patent_title] => 'NOVEL MICROBIOCIDES' [patent_app_type] => utility [patent_app_number] => 13/502368 [patent_app_country] => US [patent_app_date] => 2010-10-14 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 17772 [patent_no_of_claims] => 13 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13502368 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 8496497 [patent_doc_number] => 20120295904 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2012-11-22 [patent_title] => 'HEMATOPOIETIC GROWTH FACTOR MIMETIC SMALL MOLECULE COMPOUNDS AND THEIR USES' [patent_app_type] => utility [patent_app_number] => 13/501622 [patent_app_country] => US [patent_app_date] => 2010-10-12 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 115939 [patent_no_of_claims] => 33 [patent_no_of_ind_claims] => 7 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13501622 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6196761 [patent_doc_number] => 20110028519 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2011-02-03 [patent_title] => 'SMALL MOLECULE INSULIN MIMETICS ABSENT QUINONES' [patent_app_type] => utility [patent_app_number] => 12/901707 [patent_app_country] => US [patent_app_date] => 2010-10-11 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 7864 [patent_no_of_claims] => 15 [patent_no_of_ind_claims] => 4 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0028/20110028519.pdf [firstpage_image] =>[orig_patent_app_number] => 12901707 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 8653221 [patent_doc_number] => 08372970 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2013-02-12 [patent_title] => '8-ethyl-6-(aryl)pyrido[2,3-D]pyrimidin-7(8H)-ones for the treatment of CNS disorders' [patent_app_type] => utility [patent_app_number] => 13/500295 [patent_app_country] => US [patent_app_date] => 2010-10-08 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 3 [patent_figures_cnt] => 3 [patent_no_of_words] => 71591 [patent_no_of_claims] => 15 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 5 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13500295 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 7511468 [patent_doc_number] => 20110257178 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2011-10-20 [patent_title] => 'CANNABINOID RECEPTOR ANTAGONISTS/INVERSE AGONISTS USEFUL FOR TREATING METABOLIC DISORDERS, INCLUDING OBESITY AND DIABETES' [patent_app_type] => utility [patent_app_number] => 12/900252 [patent_app_country] => US [patent_app_date] => 2010-10-07 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 29346 [patent_no_of_claims] => 23 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0257/20110257178.pdf [firstpage_image] =>[orig_patent_app_number] => 12900252 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6149990 [patent_doc_number] => 20110021585 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2011-01-27 [patent_title] => 'DUAL-ACTING ANTIHYPERTENSIVE AGENTS' [patent_app_type] => utility [patent_app_number] => 12/898999 [patent_app_country] => US [patent_app_date] => 2010-10-06 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 40641 [patent_no_of_claims] => 25 [patent_no_of_ind_claims] => 7 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0021/20110021585.pdf [firstpage_image] =>[orig_patent_app_number] => 12898999 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 8453852 [patent_doc_number] => 20120264799 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2012-10-18 [patent_title] => 'INDANE-AMINE DERIVATIVES, THEIR PREPARATION AND USE AS MEDICAMENTS' [patent_app_type] => utility [patent_app_number] => 13/500088 [patent_app_country] => US [patent_app_date] => 2010-09-29 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 11016 [patent_no_of_claims] => 14 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13500088 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 5993550 [patent_doc_number] => 20110015203 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2011-01-20 [patent_title] => 'Viral Polymerase Inhibitors' [patent_app_type] => utility [patent_app_number] => 12/891112 [patent_app_country] => US [patent_app_date] => 2010-09-27 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 34416 [patent_no_of_claims] => 15 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0015/20110015203.pdf [firstpage_image] =>[orig_patent_app_number] => 12891112 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 8523434 [patent_doc_number] => 20120322842 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2012-12-20 [patent_title] => 'HETEROCYCYL-SUBSTITUTED-ALKYLAMINOPHENYL DERIVATIVES, THEIR PREPARATION AND USE AS MEDICAMENTS' [patent_app_type] => utility [patent_app_number] => 13/500094 [patent_app_country] => US [patent_app_date] => 2010-09-22 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 12989 [patent_no_of_claims] => 15 [patent_no_of_ind_claims] => 4 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13500094 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 9323630 [patent_doc_number] => 08658651 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2014-02-25 [patent_title] => 'Compounds that are ERK inhibitors' [patent_app_type] => utility [patent_app_number] => 13/496964 [patent_app_country] => US [patent_app_date] => 2010-09-20 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 111082 [patent_no_of_claims] => 18 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 7 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13496964 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6149887 [patent_doc_number] => 20110021482 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2011-01-27 [patent_title] => 'Novel N-Benzylamide Substituted Derivatives of 2-(Acylamido)acetic Acid and 2-(Acylamido)propionic Acids: Potent Neurological Agents' [patent_app_type] => utility [patent_app_number] => 12/884963 [patent_app_country] => US [patent_app_date] => 2010-09-17 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 61306 [patent_no_of_claims] => 41 [patent_no_of_ind_claims] => 5 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0021/20110021482.pdf [firstpage_image] =>[orig_patent_app_number] => 12884963 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 8430917 [patent_doc_number] => 20120252792 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2012-10-04 [patent_title] => 'METHODS AND COMPOSITIONS FOR MODULATING RHO-MEDIATED GENE TRANSCRIPTION' [patent_app_type] => utility [patent_app_number] => 13/496827 [patent_app_country] => US [patent_app_date] => 2010-09-17 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 3 [patent_figures_cnt] => 3 [patent_no_of_words] => 28165 [patent_no_of_claims] => 27 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13496827 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 4613701 [patent_doc_number] => 07989640 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2011-08-02 [patent_title] => 'Sulfonylpyrrolidine modulators of androgen receptor function and method' [patent_app_type] => utility [patent_app_number] => 12/880692 [patent_app_country] => US [patent_app_date] => 2010-09-13 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 22254 [patent_no_of_claims] => 5 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 6 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/07/989/07989640.pdf [firstpage_image] =>[orig_patent_app_number] => 12880692 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 8290635 [patent_doc_number] => 20120178956 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2012-07-12 [patent_title] => 'METHOD FOR PREPARING A FUNCTIONAL STRUCTURED SURFACE AND SURFACE OBTAINED BY SAID METHOD' [patent_app_type] => utility [patent_app_number] => 13/395232 [patent_app_country] => US [patent_app_date] => 2010-09-08 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 9 [patent_figures_cnt] => 9 [patent_no_of_words] => 7127 [patent_no_of_claims] => 22 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13395232 [rel_patent_id] =>[rel_patent_doc_number] =>)